CAS: 92262-58-3 - Valrocemide
Formula:C10H20N2O2
InChI:InChI=1S/C10H20N2O2/c1-3-5-8(6-4-2)10(14)12-7-9(11)13/h8H,3-7H2,1-2H3,(H2,11,13)(H,12,14)
InChI key:InChIKey=RALGCAOVRLYSMA-UHFFFAOYSA-N
SMILES:O=C(N)CNC(=O)C(CCC)CCC
- Synonyms:
- (1Beta,8Xi,11Beta,12Alpha,15Beta)-1,11,12-Trihydroxy-15-Methoxy-11,20-Epoxypicrasa-3,13(21)-Diene-2,16-Dione
- N-(2-Amino-2-oxoethyl)-2-propylpentanamide
- N-Valproylglycinamide
- Pentanamide, N-(2-amino-2-oxoethyl)-2-propyl-
- Tv 1901
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | VALROCEMIDE REF: IN-DA00GRB9CAS: 92262-58-3 | 98% | 53.00 €~142.00 € | Mon 21 Oct 24 |
 | Valrocemide REF: TM-T3562CAS: 92262-58-3 | 99.9% | 34.00 €~105.00 € | Mon 28 Oct 24 |
 | Valrocemide REF: 3D-SDA26258CAS: 92262-58-3 | Min. 95% | To inquire | Mon 02 Dec 24 |
Ref: IN-DA00GRB9
| 5mg | 53.00 € | ||
| 10mg | 65.00 € | ||
| 25mg | 82.00 € | ||
| 100mg | 142.00 € |
Estimated delivery in United States, on Monday 21 Oct 2024
Valrocemide
CAS:92262-58-3
Valrocemide (TV1901), a broad-spectrum AED, is under development by Teva and Acorda for epilepsy treatment.
Formula:
C10H20N2O2
Purity:
99.9%
Color and Shape:
Solid
Molecular weight:
200.28
Ref: TM-T3562
| 1ml | 34.00 € | ||
| 10mg | 38.00 € | ||
| 25mg | 44.00 € | ||
| 50mg | 50.00 € |
Estimated delivery in United States, on Monday 28 Oct 2024
Valrocemide
CAS:92262-58-3
Valrocemide is an amide laxative that is used to treat bowel disease. It is a …
Formula:
C10H20N2O2
Purity:
Min. 95%
Molecular weight:
200.28 g/mol
Ref: 3D-SDA26258
| 50mg | 219.00 € | ||
| 500mg | 869.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
